Universal Health price target lowered to $225 from $230 at Wells Fargo

Wells Fargo lowered the firm’s price target on Universal Health (UHS) to $225 from $230 to reflect greater uncertainty, while keeping an Overweight rating on the shares. Underlying results in Q4 were fairly strong despite some softness in demand, the firm says. Core guidance was ahead of Wells’ estimates, but does not include new Medicaid supplemental pricing in TN and D.C.